Lil­ly-backed UK biotech rais­es $72M to ad­vance its an­ti­body ap­proach

Max­ion Ther­a­peu­tics has se­cured $72 mil­lion in an over­sub­scribed Se­ries A raise, with Eli Lil­ly pitch­ing in, to ad­vance its pipeline of an­ti­body-based can­di­dates. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER